Warning letter
Bioenergy, Inc [ARCHIVED]: warning letter of Nov 1, 2010
FDA warning letter UCM232086 · Minneapolis District Office
Key facts
| Reference number | UCM232086 |
|---|---|
| Company | Bioenergy, Inc [ARCHIVED] |
| Subject | Labeling/False & Misleading Claims/Misbranded |
| Issue date | Nov 1, 2010 |
| Posted date | Nov 1, 2010 |
| Issuing office | Minneapolis District Office |
| Product type | Unknown |
| CFR sections cited | 101.9(d)(9), 101.9(c)(4), 101.9(j)(8), 101.9(j)(8)(ii), 101.9, 101.9(c)(1)(ii), 101.9(c)(2), 101.9(c)(2)(i), 101.9(c)(2)(ii), 101.9(c)(3), 101.9(c)(7), 101.9(c)(8)(iii) and 1 more |
| Country | 3 |
| Letter on fda.gov | web.archive.org |
At a glance
- 10–99 CFR sections cited
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: